Medical News

RSS

Queensland’s flooded residents warned against insect bites

The Queensland Health authorities have issued warnings to residents and tourists in the Emerald region regarding mosquitoes, biting midges (commonly known as sand flies) and black flies in areas affected by flooding. The Council insect control programs are helping with reducing the number of insects, say authorities but people still need to protect themselves to reduce the risk of being bitten in the next few weeks.

6 Jan 2011

Problems reported with Implanon contraceptive implant

Quite a few women have reported accidental and unwanted pregnancies while using Implanon, a hormone implant injected into the arm which is designed to last three years. Although the hormonal implant is described to be 99% effective, is thought to be due to problems with the initial implantation, rather than its efficacy once correctly inserted beneath the skin.

6 Jan 2011

Metabolon announces publication of 'Metabolomic Distinction and Insights into the Pathogenesis of Human Primary Dilated Cardiomyopathy'

Metabolon, the leader in metabolomics, biomarker discovery and analysis, announces the publication of "Metabolomic Distinction and Insights into the Pathogenesis of Human Primary Dilated Cardiomyopathy", in the European Journal of Clinical Investigation.

6 Jan 2011

Antigenics announces name change to Agenus

Antigenics Inc. today announced that effective immediately it is changing its name to Agenus Inc. The company's stock will continue to be traded on NASDAQ under the symbol AGEN. The new name reflects the broadening of the company's product portfolio of clinical candidates beyond autologous antigen-based vaccines, as well as its commitment to actively pursuing licensing opportunities to leverage its development capabilities and expand its product portfolio.

6 Jan 2011

Lexicon Pharmaceuticals announces clinical trial, mechanistic study results of LX4211

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering breakthrough treatments for human disease, announced data from a recently completed clinical trial and mechanistic study of a solid oral dose formulation for LX4211, a dual inhibitor of sodium-glucose co-transporters 1 and 2 (SGLT1 and SGLT2).

6 Jan 2011

Study shows clinical benefits of iniparib in combination with standard chemotherapy for triple-negative breast cancer

A current New England Journal of Medicine study indicates that the use of the PARP inhibitor iniparib in combination with standard chemotherapy to treat metastatic triple-negative breast cancer offers a significant increase in clinical benefit, a measure of durable response or disease stabilization, as well as an increase in progression-free survival.

6 Jan 2011

Scientists develop novel technology to detect immune molecules specific to Alzheimer's disease

Scientists from the Florida campus of The Scripps Research Institute, have developed a novel technology that is able to detect the presence of immune molecules specific to Alzheimer's disease in patients' blood samples. While still preliminary, the findings offer clear proof that this breakthrough technology could be used in the development of biomarkers for a range of human diseases.

6 Jan 2011

Symphogen closes €100 million stock to a group of investors

Symphogen, a private biopharmaceutical company developing superior antibody therapeutics to treat cancer, infectious and autoimmune diseases, announced today that it closed a €100 million placement of Preferred Stock to a group of investors.

6 Jan 2011

MAXIMUS signs Eligibility Support Services contract with HHSC

MAXIMUS, a leading provider of government services, announced today that it has signed the previously announced Eligibility Support Services contract with the Texas Health and Human Services Commission. The three-year base contract is valued at $315.3 million with an additional two option years.

6 Jan 2011

Presence of PML molecules could serve to diagnose condition of tumor: Researchers

Cancer cells reproduce by dividing in two, but a molecule known as PML limits how many times this can happen, according to researchers lead by Dr. Gerardo Ferbeyre of the University of Montreal's Department of Biochemistry.

6 Jan 2011

New technique to analyze and quantify changes in protein

A scientist from the Florida campus of The Scripps Research Institute has devised a new method of analyzing and quantifying changes in proteins that result from a common chemical process. The new findings could provide new insights into the effects of a highly destructive form of stress on proteins in various disease models, particularly cancer.

6 Jan 2011

Skilled Healthcare Group updates 2010 full year non-GAAP earnings estimates

Skilled Healthcare Group, Inc. today announced it has updated its 2010 full year non-GAAP earnings estimates and expects consolidated revenue to be approximately $816 million to $819 million, Adjusted EBITDAR to be approximately $138.9 million to $140.7 million and Adjusted EBITDA to be approximately $119.7 million to $121.5 million. The Company expects adjusted earnings per diluted share for 2010 to be between $1.01 and $1.04.

6 Jan 2011

Medical experts issue warning about common practice of tablet splitting

Medical experts have issued a warning about the common practice of tablet splitting, after a study found that nearly a third of the split fragments deviated from recommended dosages by 15 per cent or more.

6 Jan 2011

Report urges Minnesotans to protect, preserve water resources

The University of Minnesota's Water Resources Center has authored a first-ever, comprehensive report designed to protect and preserve Minnesota's lakes, rivers and groundwater for the 21st century and beyond.

6 Jan 2011

Researchers find intervention is less effective for surgical and neurological ICU patients

While a much hailed communication intervention works for families making decisions for chronically-ill loved ones in medical intensive care units, Case Western Reserve University researchers found the intervention was less effective for surgical and neurological ICU patients.

6 Jan 2011

VEREGEN Ointment added as new therapeutic option in 2010 CDC STD Treatment Guidelines

PharmaDerm, a division of Nycomed US Inc., announced today that VEREGEN (sinecatechins) Ointment, 15%, a topical medication for the treatment of external genital and perianal warts, has been added as a new therapeutic option in the 2010 Centers for Disease Control and Prevention Sexually Transmitted Diseases Treatment Guidelines.

6 Jan 2011

Californians can now access information about local healthcare providers using MyHealthResource

Realizing the New Year's resolution of "good health" could be just a click of the mouse away - even for Californians without adequate health insurance, thanks to a free, online resource from Californians for Patient Care. Using MyHealthResource, available at www.calpatientcare.org, Californians can access information about local healthcare providers that provide primary, dental, vision and mental healthcare services to the uninsured and underinsured.

6 Jan 2011

The Ensign Group procures $35 million seven-year term loan from RBS Asset Finance

The Ensign Group, the parent company of the Ensign group of skilled nursing, rehabilitative care services, hospice care and assisted living companies, announced that a group of its real estate holding subsidiaries has procured a US$35 million seven-year term loan from RBS Asset Finance, Inc., an affiliate of The Royal Bank of Scotland Group.

6 Jan 2011

Findings of AM095 in various in vitro, in vivo models of fibrotic disease published in JPET

Amira Pharmaceuticals, Inc. announced today the publication of its findings in the Journal of Pharmacology and Experimental Therapeutics which describes the biologic effects and the characterization of AM095, a lysophosphatidic acid receptor 1 antagonist, in various in vitro and in vivo models of fibrotic disease.

6 Jan 2011

Research: Tomatoes can tackle onset of vascular diseases

They are the most widely produced fruit in the world and now scientists in Japan have discovered that tomatoes contain a nutrient which could tackle the onset of vascular diseases.

6 Jan 2011

Medical News

Queensland’s flooded residents warned against insect bites

Problems reported with Implanon contraceptive implant

Metabolon announces publication of 'Metabolomic Distinction and Insights into the Pathogenesis of Human Primary Dilated Cardiomyopathy'

Antigenics announces name change to Agenus

Lexicon Pharmaceuticals announces clinical trial, mechanistic study results of LX4211

Study shows clinical benefits of iniparib in combination with standard chemotherapy for triple-negative breast cancer

Scientists develop novel technology to detect immune molecules specific to Alzheimer's disease

Symphogen closes €100 million stock to a group of investors

MAXIMUS signs Eligibility Support Services contract with HHSC

Presence of PML molecules could serve to diagnose condition of tumor: Researchers

New technique to analyze and quantify changes in protein

Skilled Healthcare Group updates 2010 full year non-GAAP earnings estimates

Medical experts issue warning about common practice of tablet splitting

Report urges Minnesotans to protect, preserve water resources

Researchers find intervention is less effective for surgical and neurological ICU patients

VEREGEN Ointment added as new therapeutic option in 2010 CDC STD Treatment Guidelines

Californians can now access information about local healthcare providers using MyHealthResource

The Ensign Group procures $35 million seven-year term loan from RBS Asset Finance

Findings of AM095 in various in vitro, in vivo models of fibrotic disease published in JPET

Research: Tomatoes can tackle onset of vascular diseases

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News